Pediatric Healthcare Market Report By Facility Type (Children's Hospitals, Pediatric Clinics, Pediatric Intensive Care Units (PICUs), Neonatal Intensive Care Units (NICUs), Pediatric Specialty Centers, Others), By Disease/Condition (Respiratory Disorders, Infectious Diseases, Genetic Disorders, Developmental Disorders, Chronic Illnesses, Mental Health Disorders, Others), By Payment Mode, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
-
26169
-
May 2024
-
321
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
Report Overview
The Global Pediatric Healthcare Market size is expected to be worth around USD 78.0 Billion by 2033, from USD 38.2 Billion in 2023, growing at a CAGR of 7.6% during the forecast period from 2024 to 2033.
The Pediatric Healthcare Market focuses on medical services and products for children from birth to adolescence. It includes healthcare providers, hospitals, clinics, and specialized medical equipment. This market covers preventive care, diagnosis, treatment, and management of illnesses specific to children. Key players include pediatricians, nurses, pharmaceutical companies, and medical device manufacturers.
The market aims to improve child health outcomes, offering tailored healthcare solutions for growth and development stages. It also emphasizes innovation in treatments and technologies to address unique pediatric needs. The market's growth is driven by increasing awareness of child health, technological advancements, and rising healthcare investments.
The Pediatric Healthcare Market is experiencing significant growth, driven by the increasing need for specialized medical care for children. Each year in the United States, an estimated 58,000-80,000 children under five are hospitalized due to respiratory syncytial virus (RSV) infection. This high hospitalization rate underscores the critical demand for effective pediatric healthcare solutions.
Among the 5.2 million pediatric hospitalizations, newborns and infants under one year old represent the majority, accounting for 76.7% of these hospitalizations and 60.5% of total pediatric hospital costs. The average length of stay (LOS) and hospitalization costs vary significantly by age group, with costs being lowest for neonates at $5,700 and highest for infants under one at $24,100.
These statistics highlight the substantial economic impact and the necessity for tailored healthcare services in this market segment. The pediatric healthcare market's dynamics are influenced by advancements in medical technology, increasing healthcare investments, and a growing emphasis on early diagnosis and treatment of pediatric conditions. There is a notable shift towards innovative treatments and technologies, aiming to improve health outcomes and reduce hospitalization costs. Healthcare providers are increasingly focusing on preventive care and effective management of chronic conditions in children to mitigate long-term health issues.
This market's growth prospects are further enhanced by rising awareness of child health and the development of specialized medical devices and pharmaceuticals tailored for pediatric use. As the demand for comprehensive pediatric healthcare continues to rise, stakeholders are likely to see significant opportunities for investment and innovation, driving the market's expansion and enhancing the quality of care provided to young patients.
Key Takeaways
- Market Value: The Global Pediatric Healthcare Market is projected to reach approximately USD 78.0 Billion by 2033, experiencing robust growth from USD 38.2 Billion in 2023. This growth is driven by a strong CAGR of 7.6% during the forecast period spanning from 2024 to 2033.
- Facility Type Analysis: Children's Hospitals emerge as the dominant segment within the Pediatric Healthcare Market, commanding a substantial 45% market share.
- Disease/Condition Analysis: Respiratory Disorders lead the sub-segments in the Pediatric Healthcare Market, capturing approximately 30% of the market share.
- Payment Mode Analysis: Public Health Insurance emerges as the dominant payment mode, covering around 50% of pediatric healthcare services.
- North America dominates the Pediatric Healthcare Market with a significant 37.6% market share, driven by robust healthcare infrastructure and extensive insurance coverage.
- Europe follows closely behind, accounting for approximately 30.2% of the market, reflecting the region's emphasis on child health and well-being.
Driving Factors
Increasing Prevalence of Chronic Diseases in Children Drives Market Growth
The increasing prevalence of chronic diseases among children, such as asthma, diabetes, and obesity, significantly drives the demand for pediatric healthcare services. The Centers for Disease Control and Prevention (CDC) reports that the prevalence of childhood obesity in the United States has tripled since the 1970s, with nearly one in five children aged 6-19 being obese. This alarming rise in chronic conditions necessitates more frequent medical consultations, specialized treatments, and ongoing care management, thereby expanding the pediatric healthcare market. These chronic diseases often require long-term treatment plans, specialized medical equipment, and continuous monitoring, creating a sustained demand for healthcare services tailored to children.
This trend is compounded by the increasing awareness of the long-term health impacts of these chronic conditions, leading to a greater emphasis on early diagnosis and preventive care. Healthcare providers are investing in specialized pediatric units and training healthcare professionals to manage and treat these conditions effectively. Additionally, the rise in chronic diseases among children is prompting advancements in pediatric pharmaceuticals and medical devices designed to address the unique needs of young patients. As a result, the pediatric healthcare market is experiencing robust growth, driven by the necessity to provide comprehensive care for children with chronic health issues.
Technological Advancements Drive Market Growth
Technological advancements in pediatric healthcare have significantly improved the quality of care for young patients, driving market growth. The development of advanced diagnostic tools, minimally invasive surgical techniques, and innovative pediatric medical devices has transformed the landscape of pediatric healthcare. For instance, robotic-assisted surgery has revolutionized pediatric surgical procedures by offering greater precision, smaller incisions, and faster recovery times. These technological innovations not only enhance patient outcomes but also reduce the overall cost of care, making advanced treatments more accessible and efficient.
Furthermore, advancements in diagnostic technology have enabled earlier detection and more accurate diagnosis of pediatric conditions, leading to timely and effective interventions. Innovations such as portable imaging devices, advanced genetic testing, and telemedicine platforms are expanding the reach of pediatric healthcare services, particularly in remote and underserved areas. These technologies facilitate better monitoring and management of chronic diseases, improving the overall health and well-being of children. As technology continues to evolve, the pediatric healthcare market is poised for continued growth, driven by the ongoing development and adoption of cutting-edge medical technologies.
Government Initiatives and Healthcare Reforms Drive Market Growth
Government initiatives and healthcare reforms play a crucial role in driving the growth of the pediatric healthcare market. Many governments worldwide have implemented policies and programs to enhance access to pediatric healthcare services and promote preventive care. These initiatives often include substantial investments in pediatric research, the establishment of specialized healthcare facilities, and educational campaigns aimed at raising awareness about child health issues. Such efforts are crucial in improving the availability and quality of pediatric healthcare services, particularly for underserved populations.
For example, various government policies focus on increasing funding for pediatric healthcare infrastructure, supporting the development of new treatments, and ensuring affordable healthcare access for all children. These initiatives are complemented by healthcare reforms that prioritize child health, such as expanding insurance coverage for pediatric services and incentivizing the adoption of innovative healthcare technologies. By promoting preventive care and early intervention, these government efforts contribute to better health outcomes for children, reducing the incidence of chronic diseases and lowering overall healthcare costs. As a result, the pediatric healthcare market benefits from a more supportive regulatory environment and increased public and private sector investments, driving its growth and expansion.
Restraining Factors
High Costs and Limited Access to Healthcare Restrain Market Growth
High costs and limited access to healthcare are major barriers to the growth of the Pediatric Healthcare Market. The expense of pediatric healthcare services, including specialized treatments and advanced medical equipment, often poses a financial challenge for many families, especially in low- and middle-income countries. For example, the average cost of hospitalization for infants under one year is $24,100, which is significantly higher compared to neonates at $5,700.
These high costs can deter families from seeking necessary medical care for their children. Additionally, limited access to healthcare facilities and specialists in remote or underserved areas further restricts the delivery of quality pediatric care. This lack of access can lead to delayed diagnoses and treatment, negatively impacting child health outcomes. Together, these factors create substantial obstacles for the market, limiting its expansion and the ability to provide comprehensive care to all children.
Shortage of Pediatric Healthcare Professionals Restrains Market Growth
A shortage of pediatric healthcare professionals is a significant restraint on the Pediatric Healthcare Market. Many regions face a critical lack of trained pediatricians, pediatric nurses, and other specialists in child care. This shortage results in longer wait times for appointments, delayed diagnoses, and potentially suboptimal care for pediatric patients.
Furthermore, the uneven distribution of these professionals, with a higher concentration in urban areas, exacerbates accessibility challenges in rural regions. This imbalance means that children in rural areas often have limited access to specialized pediatric care, leading to disparities in health outcomes. The shortage of healthcare professionals and their uneven distribution hinder the market's ability to meet the growing demand for pediatric healthcare services, thereby restraining its overall growth and effectiveness in delivering quality care.
Facility Type Analysis
Children's Hospitals Dominate with 45% Due to Specialized Care and Comprehensive Services
Children’s hospitals dominate the Pediatric Healthcare Market, accounting for approximately 45% of the market share. These hospitals are specifically designed to provide comprehensive medical care for children from birth through adolescence, offering a wide range of specialized services and treatments. They are equipped with advanced medical technology and staffed by healthcare professionals trained in pediatric care, which enhances their ability to diagnose and treat complex pediatric conditions effectively. The presence of specialized departments, such as pediatric oncology, cardiology, and neurology, contributes to their dominance in the market. Children’s hospitals also play a critical role in medical research and the development of new treatments and therapies for pediatric diseases, further solidifying their market position.
Additionally, children's hospitals are often located in urban areas, making them accessible to a large population base. They serve as referral centers for other healthcare facilities, providing specialized care that is not available in general hospitals or clinics. This central role in the pediatric healthcare ecosystem drives their significant market share. Moreover, children’s hospitals often receive substantial funding from both government and private sources, supporting their operations and enabling continuous improvements in healthcare delivery. This financial support is crucial for maintaining high standards of care and ensuring the availability of cutting-edge treatments and technologies.
Other segments in the facility type category include pediatric clinics, PICUs, NICUs, and pediatric specialty centers. Pediatric clinics provide primary and preventive care, serving as the first point of contact for many children. They play a vital role in early diagnosis and management of common pediatric conditions. PICUs and NICUs offer critical care services for seriously ill or premature infants, providing life-saving treatments and intensive monitoring. Pediatric specialty centers focus on specific medical areas, such as orthopedics or endocrinology, offering specialized treatments and expertise. Each of these segments contributes to the overall growth of the pediatric healthcare market by addressing different aspects of child health care needs.
Disease/Condition Analysis
Respiratory Disorders Dominate with 30% Due to High Incidence and Frequent Hospitalizations
Respiratory disorders are the leading sub-segment in the Pediatric Healthcare Market, representing around 30% of the market share. The high incidence of respiratory conditions such as asthma, bronchitis, and pneumonia among children drives significant demand for pediatric healthcare services. For instance, respiratory syncytial virus (RSV) infections result in an estimated 58,000-80,000 hospitalizations of children under five each year in the United States alone. The frequent hospitalizations and need for continuous medical care for these conditions underscore their dominance in the market.
The management of respiratory disorders often requires ongoing treatment, including medication, respiratory therapy, and frequent monitoring, contributing to the sustained demand for healthcare services in this segment. Advances in medical technology, such as portable nebulizers and improved inhalation devices, have enhanced the treatment and management of these conditions, further driving market growth. Additionally, the development of new medications and therapies targeting respiratory disorders in children continues to expand treatment options and improve patient outcomes.
Other segments under disease/condition include infectious diseases, genetic disorders, developmental disorders, chronic illnesses, and mental health disorders. Infectious diseases, such as influenza and meningitis, also represent a significant portion of the market, requiring prompt diagnosis and treatment to prevent complications. Genetic and developmental disorders necessitate specialized care and long-term management, contributing to the demand for pediatric healthcare services. Chronic illnesses like asthma and diabetes require ongoing medical attention and monitoring, while mental health disorders in children are increasingly recognized and addressed, highlighting the need for comprehensive pediatric mental health services. Each of these segments plays a crucial role in the overall growth and diversification of the pediatric healthcare market.
Payment Mode Analysis
Public Health Insurance Dominates with 50% Due to Broad Coverage and Accessibility
Public health insurance is the dominant payment mode in the Pediatric Healthcare Market, covering approximately 50% of pediatric healthcare services. Programs such as Medicaid and the Children’s Health Insurance Program (CHIP) in the United States provide comprehensive healthcare coverage for children from low-income families, ensuring access to essential medical services. This broad coverage significantly reduces the financial burden on families, enabling them to seek necessary medical care for their children without incurring high out-of-pocket costs. The extensive reach and accessibility of public health insurance programs drive their dominance in the market.
Public health insurance also supports preventive care services, including vaccinations, routine check-ups, and screenings, which are crucial for maintaining child health and preventing the onset of chronic conditions. The emphasis on preventive care helps reduce overall healthcare costs and improves health outcomes, contributing to the growth of the pediatric healthcare market. Furthermore, government initiatives aimed at expanding public health insurance coverage and improving healthcare access for children continue to strengthen this segment’s position in the market.
Other payment modes in the market include private health insurance, out-of-pocket payments, and other forms of payment. Private health insurance provides coverage for children in families with employer-sponsored or individually purchased plans, offering a wide range of benefits and access to a broad network of healthcare providers. Out-of-pocket payments, though less common, are significant in regions with limited insurance coverage, where families pay directly for medical services. This payment mode often leads to financial strain and limits access to necessary healthcare for many families. Each of these payment modes influences the pediatric healthcare market by shaping the accessibility and affordability of medical services for children, contributing to the market's overall dynamics and growth.
Key Market Segments
By Facility Type
- Children's Hospitals
- Pediatric Clinics
- Pediatric Intensive Care Units (PICUs)
- Neonatal Intensive Care Units (NICUs)
- Pediatric Specialty Centers
- Others
By Disease/Condition
- Respiratory Disorders
- Infectious Diseases
- Genetic Disorders
- Developmental Disorders
- Chronic Illnesses (e.g., Asthma, Diabetes)
- Mental Health Disorders
- Others
By Payment Mode
- Public Health Insurance
- Private Health Insurance
- Out-of-pocket Payments
- Others
Growth Opportunities
Preventive Care and Health Education Offers Growth Opportunity
The growing emphasis on preventive care and health education presents significant growth opportunities in the Pediatric Healthcare Market. Initiatives promoting healthy lifestyles, proper nutrition, and regular physical activity are crucial in preventing chronic conditions like obesity and diabetes in children. For example, educational programs and awareness campaigns targeting parents, caregivers, and children encourage the adoption of healthy habits from an early age.
These programs are often supported by healthcare organizations and governments, which invest in resources to enhance community health education. By reducing the incidence of childhood diseases through preventive measures, the demand for pediatric healthcare services is expected to increase, driving market growth. This focus on prevention not only improves long-term health outcomes for children but also reduces healthcare costs, creating a sustainable model for pediatric healthcare expansion.
Personalized Pediatric Therapeutics Offer Growth Opportunity
Advancements in precision medicine and genomics provide significant opportunities for growth in the Pediatric Healthcare Market through the development of personalized pediatric therapeutics. Leveraging genetic testing and biomarker analysis, healthcare providers can create tailored treatment plans that align with individual genetic profiles and specific disease characteristics.
This personalized approach optimizes dosages, minimizes adverse effects, and enhances treatment efficacy, leading to improved patient outcomes. The ability to offer customized therapies enhances the quality of pediatric care and addresses unmet medical needs, particularly for children with complex or rare conditions. As precision medicine continues to evolve, it is expected to drive innovation in pediatric therapeutics, expanding the market and improving healthcare delivery for young patients.
Trending Factors
Digital Health Solutions Are Trending Factors
Digital health solutions are significantly trending in the Pediatric Healthcare Market, driven by the growing adoption of mobile applications, wearable devices, and cloud-based platforms for monitoring and managing pediatric health. These technologies empower patients and caregivers by providing real-time access to health data, enhancing self-care, and facilitating improved communication with healthcare providers.
Companies like Glooko and Dexcom are leading this trend with solutions specifically designed for pediatric diabetes management, offering tools that track glucose levels and provide actionable insights. The convenience and accessibility of digital health solutions are revolutionizing pediatric care, making it more efficient and patient-centered. This trend is expected to continue, as the integration of digital health technologies in pediatric care enhances disease management and improves overall health outcomes for children.
Regenerative Medicine and Stem Cell Therapies Are Trending Factors
Regenerative medicine and stem cell therapies are emerging as trending factors in the Pediatric Healthcare Market, offering promising new treatments for a range of pediatric conditions. These advanced therapies focus on repairing or replacing damaged tissues and organs, providing hope for conditions that were previously difficult to treat.
Companies are conducting clinical trials on stem cell therapies for conditions such as graft-versus-host disease and bronchopulmonary dysplasia in children. The potential of these therapies to treat genetic disorders, neurological diseases, and injuries positions them as a significant trend in pediatric healthcare. As research and clinical trials progress, regenerative medicine and stem cell therapies are expected to expand treatment options and improve outcomes for pediatric patients, driving growth in the market.
Regional Analysis
North America Dominates with 37.6% Market Share
North America holds a 37.6% share of the Pediatric Healthcare Market, making it the leading region globally. This dominance is driven by advanced healthcare infrastructure, high healthcare spending, and significant investments in pediatric research and development. The presence of leading pharmaceutical companies and healthcare providers also contributes to North America’s market strength. Additionally, robust public health insurance programs like Medicaid and CHIP improve access to pediatric care, further enhancing the region's market position.
Key factors contributing to North America’s high market share include a well-established healthcare system and significant government funding for pediatric healthcare services. The region’s focus on innovation in medical technology and pharmaceuticals plays a crucial role in its market dominance. Additionally, North America benefits from a high prevalence of chronic pediatric conditions, increasing demand for specialized healthcare services.
North America's healthcare landscape features a strong emphasis on technological advancements and preventive care. The region’s high expenditure on healthcare, which accounts for a significant portion of GDP, supports the continuous development of advanced pediatric treatments and technologies. The integration of digital health solutions and a focus on personalized medicine further drive the market's growth in this region.
Europe Market Share and Growth
Europe accounts for approximately 30.2% of the Pediatric Healthcare Market. The region's strong healthcare infrastructure, coupled with significant investments in pediatric research and development, drives its market share. Europe also benefits from a well-established public health system, enhancing access to pediatric care. The region is expected to see steady growth, supported by advancements in medical technology and increasing focus on preventive care.
Asia Pacific Market Share and Growth
Asia Pacific holds around 18.7% of the Pediatric Healthcare Market, with rapid growth driven by increasing healthcare investments and rising awareness of child health issues. The region's large population base and expanding middle class contribute to the growing demand for pediatric healthcare services. As healthcare infrastructure continues to improve, Asia Pacific is expected to see significant market expansion.
Middle East & Africa Market Share and Growth
The Middle East & Africa region represents approximately 7.9% of the Pediatric Healthcare Market. Growth in this region is driven by increasing government initiatives to improve healthcare infrastructure and access. Efforts to expand healthcare coverage and investments in medical technology are expected to enhance the region's market presence.
Latin America Market Share and Growth
Latin America accounts for about 5.6% of the Pediatric Healthcare Market. The region's market growth is supported by improving healthcare systems and increasing investments in pediatric care. Government initiatives to enhance healthcare access and the adoption of advanced medical technologies are expected to drive further market growth in Latin America.
Key Regions and Countries
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
The Pediatric Healthcare Market is shaped by a mix of established pharmaceutical giants and specialized healthcare service providers, each contributing uniquely to this sector's growth. Companies like Bristol-Myers Squibb Company, Gilead Sciences, Novartis AG, Eli Lilly and Company, and Pfizer Inc. are at the forefront due to their extensive drug development programs that focus on pediatric medications. These companies are crucial for advancing new treatments that address a range of childhood diseases, thereby setting high standards in pediatric care.
In addition to pharmaceutical innovations, service providers such as Bayada Home Health Care, Aveanna Healthcare, BrightStar Care, and EnViva Paediatric Care play pivotal roles in delivering specialized medical services directly to young patients. These organizations are strategically positioned to provide comprehensive home health and personalized care solutions, making healthcare more accessible to children with chronic or special medical needs.
Abbott Laboratories contributes significantly through nutritional and medical products tailored for children, enhancing the overall health outcomes of this demographic. Similarly, Interim Healthcare Inc. and DJK Home Healthcare LLC extend their impact by offering supportive home care services that cater to the complex needs of pediatric patients, ensuring continuity of care outside traditional medical settings.
Together, these key players not only enhance therapeutic options available for children but also ensure holistic and continuous care, crucial for the sector’s growth and the well-being of young patients worldwide.
Market Key Players
- Bayada Home Health Care
- GlaxoSmithKline
- Bristol-Myers Squibb Company
- DJK Home Healthcare LLC
- Aveanna Healthcare
- Gilead Sciences
- Novartis AG
- BrightStar Care
- EnViva Paediatric Care
- Eli Lilly and Company
- Pfizer Inc.
- Abbott Laboratories
- Interim Healthcare Inc.
Recent Developments
- On May 2024, Nemours Children's Health, one of the nation's largest multistate pediatric health systems, and the University of Central Florida (UCF) announced a formalized, expanded partnership aimed at improving the health of children in Central Florida and beyond.
- On April 2024, Mercer University School of Medicine (MUSM) and the Georgia Rural Health Innovation Center (GRHIC) expanded their major rural pediatric health care initiative to newly selected hospitals.
- On April 2024, Ciba Health launched its Pediatric Metabolic Program, a comprehensive and personalized approach to pediatric healthcare that focuses on addressing the root cause of metabolic health issues in children.
- On January 2024, Rainbow Children's Hospital in India announced a partnership with the Ministry of Health in Zanzibar to enhance pediatric healthcare.
Report Scope
Report Features Description Market Value (2023) USD 38.2 Billion Forecast Revenue (2033) USD 78.0 Billion CAGR (2024-2033) 7.6% Base Year for Estimation 2023 Historic Period 2018-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Facility Type (Children's Hospitals, Pediatric Clinics, Pediatric Intensive Care Units (PICUs), Neonatal Intensive Care Units (NICUs), Pediatric Specialty Centers, Others), By Disease/Condition (Respiratory Disorders, Infectious Diseases, Genetic Disorders, Developmental Disorders, Chronic Illnesses (e.g., Asthma, Diabetes), Mental Health Disorders, Others), By Payment Mode (Public Health Insurance, Private Health Insurance, Out-of-pocket Payments, Others) Regional Analysis North America - The US, Canada, & Mexico; Western Europe - Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe - Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC - China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America - Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa - Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Bayada Home Health Care, Bristol-Myers Squibb Company, DJK Home Healthcare LLC, Aveanna Healthcare, Gilead Sciences, Novartis AG, BrightStar Care, EnViva Paediatric Care, Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Interim Healthcare Inc. Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
-
- GlaxoSmithKline
- AstraZeneca
- Pfizer
- Merck
- Boehringer Ingelheim
- Pediapharm
- Sanofi
- Gilead Sciences
- Eisai
- Mylan